Superworth

Vor Biopharma market cap VOR

Share price times shares outstanding: what the whole company sells for, since 2021.

Today, Nov 2, 2026
$1.2B
Highest close in our data
$1.5B
Sep 2026

Vor Biopharma is worth $1.2B at the close on Nov 2, 2026, at $19.25 a share.

That is up 898% over the last year and up 77% over five years.

Its highest close in our data was $1.5B in Sep 2026.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$1.2B$121.2M$1.5B+672%
2025$153.2M$18.9M$312.4M+76%
2024$87.2M$45.8M$166.8M−43%
2023$152.6M$119.3M$390.3M−41%
2022$257.1M$145M$394.5M−41%
2021$433.3M$433.3M$910.8Mn/a

Against its peers

Companies in Biotechnology nearest Vor Biopharma's size, closest first, today.

CompanyMarket cap
VORVor Biopharma$1.2B
MGTXMeiraGTx$895.1M
VCELVericel$2.1B
ADMAAdma Biologics$2.5B
PLXProtalix BioTherapeutics$206.3M
KRYSKrystal Biotech$8.8B
RGENRepligen$9.8B
TECHBIO-TECHNE$11.4B
Peer median$2.5B

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on Vor Biopharma

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.